February 18, 2000


Tuesday May 16

7 a.m.-8:30 a.m.

Industry-Supported Symposia

IS29. Managing Psychoses Across the Age Spectrum (Part 2) Supported by AstraZeneca Pharmaceuticals

A. Psychosis Genotypes and Phenotypes: Diagnosis and Treatment Henry A. Nasrallah, M.D.

B. Geriatric Psychoses Dilip V. Jeste, M.D.

IS30. Antiepileptic Drugs in Psychiatric Disorders (Part 2) Supported by Parke-Davis

A. Use of Antiepileptics in Drug Abuse Detoxification Sylvia J. Dennison, M.D.

B. Negative Psychotropic Effects of Antiepileptic Drugs F. Moises Gaviria, M.D.

IS31. Evidence-Based Management of Refractory Depression (Part 2) Supported by Organon Inc.

A. Juvenile Depression: Diagnosis and Treatment Jefferson B. Prince, M.D.

B. Divergence of Practice from Evidence for Refractory Depression Andrew A. Nierenberg, M.D.

IS32. Lengthening the Fuse: Treatment of Aggression (Part 2) Supported by Abbott Laboratories

A. Impulsivity in Aggression: BPD and Autism Eric Hollander, M.D.

B. Agitation and Aggression in the Elderly Pierre N. Tariot, M.D.

IS33. New Clinical Advances in Anxiety and Depression (Part 2) Supported by Bristol-Myers Squibb Company

A. Clinical and Biological Factors in Chronic Depression David L. Dunner, M.D.

B. New Treatment Findings on Combining Pharmacotherapy and Psychotherapy for Chronic Depression Martin B. Keller, M.D.

7:30 a.m.-6 p.m.

Registration/Course Enrollment Open

8 a.m.-Noon

CME Courses 63-69

9 a.m.-10:30 a.m.

Clinical Case Conference 2. Roslyn Seligman, M.D., on Affect Dysregulation: Clinical Issues and Psychotherapy (open to APA members only)

Debate 2. Resolved: Recovery Memories Can Be Ethically and Appropriately Integrated into the Treatment of Trauma Moderator: William H. Sledge, M.D. Affirmative: Paul S. Appelbaum, M.D., and David Spiegel, M.D. Negative: Paul R. McHugh, M.D., and Sally L. Satel, M.D.

Discussion Groups

7. Daniel K. Winstead, M.D., on Restraints and Seclusion Revisited

8. Catherine C. Chang-Crone, M.D., on Consultation-Liaison Psychiatry: Highlighting Subspeciality Options Through Discussion of Transplant Psychiatry (for residents only)

9. Arthur T. Meyerson, M.D., on Current Trends in Community Psychiatry

Lectures

L11. To Be Announced Jambur V. Ananth, M.D., APA’s George Tarjan Award Lecture

L12. To Be Announced Paul Ricouer, M.D., APA’s Oskar Pfister Award Lecture

L13. Thinking While Listening Robert Michels, M.D., Distinguished Psychiatrist Lecture Series

Master Education Clinical Consultations

5. James H. Scully Jr., M.D., on Resident Supervision (open to APA members only)

6. Malkah T. Notman, M.D., on Psychotherapy: Gender Issues (open to APA members only)

7. Sheldon I. Miller, M.D., on Dual Diagnosis National Institute on Alcohol Abuse and Alcoholism (open to APA members only)

New Research Oral/Slide Sessions 5-6

Component Workshops

CW18. Victims in the Workplace: Awful to Optimal Outcomes APA Committee on Psychiatry in the Workplace Chairperson: Leonard T. Sperry, M.D.

CW19. Mental Illness in Psychiatrists: Training and Beyond National Alliance on Mental Illness Co-Chairpersons: Michael Myers, M.D., and Leah J. Dickstein, M.D.

CW20. Misuse and Abuse of Psychiatry: Clinical Issues APA Committee on Abuse of Psychiatry and Psychiatrists Co-Chairpersons: Renato D. Alarcon, M.D., and Jose E. De La Gandara, M.D.

CW21. ABPN Examiners and ABPN Examinees APA Committee of Early Career Psychiatrists and APA Assembly Committee of Early Career Psychiatrists Chairperson: Anand Pandya, M.D.

CW22. Racism and Psychopathology APA Committee of Black Psychiatrists Chairperson: Michelle O. Clark, M.D.

Issue Workshops

IW22. Career Strategies Y2K: Stay Generative and Stimulated Chairperson: Joel Yager, M.D.

IW23. Portrayal of Psychiatry in Recent American Film Chairperson: Steven E. Pflanz, M.D.

IW24. When Can Incompetent Persons Be Research Subjects? Chairperson: Herbert S. Peyser, M.D.

IW25. Developing a Statewide Psychiatric Disaster Plan Chairperson: Sheila G. Jowsey, M.D.

IW26. Using Treatment Outcomes in Residency Training Co-Chairpersons: Winston Brown, M.D., and James A. Clardy , M.D.

IW27. Split Treatment: Clinical, Legal, and Ethical Issues Co-Chairpersons: Robert I. Simon, M.D., and Donald J. Meyer, M.D.

IW28. Understanding the Dynamics of Abusive Relationships Chairperson: Gary J. Maier, M.D.

IW29. Psychiatric Implications of Weapons of Mass Destruction Chairperson: Dickson Diamond, M.D.

IW30. Telepsychiatry Services: From Design to Global Implications Psychiatric Society of Informatics Co-Chairpersons: Harry Karlinsky, M.D. and Douglas A. Urness, M.D.

IW31. Doctor-Patient Relationship in Chekhov’s Writing Chairperson: Lesley R. Dickson, M.D.

IW32. A Chair’s Life: Ethiopia, Taiwan, Geneva, Atlanta, and Los Angeles Co-Chairpersons: Milton H. Miller, M.D., and Charles B. Nemeroff, M.D.

IW33. Academic/Corrections Models of Mental Health Care Co-Chairpersons: Robert L. Trestman, M.D., and Kenneth L. Appelbaum, M.D.

IW34. Poetry and Medicine Co-Chairpersons: Janis B. Petzel, M.D., and Chelsea L. Chesen, M.D.

IW35. Beethoven and His Creative Evolution Chairperson: Richard Kogan, M.D.

IW36. Diagnosis and Treatment of Hepatitis C in Mental Health Settings Chairperson: Peter Hauser, M.D.

IW37. Trauma Survivors: Heterogeneity of Psychiatric Manifestations Chairperson: Andrei Novac, M.D.

9 a.m.–11 a.m.

Media Sessions

Session 10. A Widow’s Journey to Vietnam: Hope and Healing

16. Regret to Inform

Session 11. The Doctor-Patient Relationship: Boundary Issues

17. Uncertain Borders Part 1: Boundary Issues in Psychotherapy

18. Uncertain Borders Part 2: Sexual Boundary Violations

Research Advances in Medicine

The Treatment Controversy in Alcohol Detoxification National Institute on Alcohol Abuse and Alcoholism in Collaboration with the American Academy of Addiction Psychiatry Chairperson: Thomas R. Kosten, M.D.

9 a.m.-Noon

Continuous Clinical Case Conference, Part 2 Arthur J. Barsky III, M.D., on Patients with Medically Unexplained Physical Symptoms: Psychiatry and Family Medicine as Physician Partners (open to APA members only) American Academy of Family Physicians

Telecommunication Session

Session 1. Sex, Hate, and Violence on the Internet

1. Pornography on the Web: What’s the Big Deal?

2. Hate Groups, Adolescents, and the Internet

3. Domestic Violence: A CME Web Course

9 a.m - 12:30 p.m.

Review of Psychiatry, Part II: Psychotherapy of the Personality Disorders Co-Chairpersons: John G. Gunderson, M.D. and Glen O. Gabbard, M.D.

5. Empirical Studies of Psychotherapy for Personality Disorders J. Christopher Perry, M.D.

6. Psychodynamic Psychotherapy of BPD John G. Gunderson, M.D.

7. Combining Medication with Psychotherapy in the Treatment of Personality Disorders Glen O. Gabbard, M.D.

8. Gradations of Antisociality and Responsivity to Psychosocial Therapies Michael H. Stone, M.D.

9. Cognitive Therapy of Personality Disorders Peter Tyrer, M.D.

9 a.m.-4 p.m.

CME Courses 70-77

10 a.m.-6 p.m.

Exhibits Open

Publishers’ Bookfair Open

APA Resource Center Open

11 a.m.-12:30 p.m.

Discussion Groups

10. Carol A. Bernstein, M.D., on Clinical Training in Psychiatry: A Moving Target

11. D.F. Rendinell, M.D., on Patient Rights in Psychotherapy

Lectures

L14. Mental Health Problems in Taiwan: Issues, Dilemmas, and Challenges Eng-Kung Yeh, M.D., APA’s Kun-Po Soo Award Lecture

L15. To Be Announced George McGovern, APA’s Patient Advocacy Award Lecture

Master Education Clinical Consultations

7. Sheldon I. Miller, M.D., on Dual Diagnosis National Institute on Alcohol Abuse and Alcoholism (open to APA members only)

8. Jerry M. Wiener, M.D., on The Effects and Management of Childhood Trauma in the Transference (open to APA members only)

9. David W. Preven, M.D., on The Impaired Physician: Disciplinary and Therapeutic Issues (open to APA members only)

Medical Update 2. Charles Strom, M.D., on Seventeen Ways to Have a Baby: Reproduction in the 21st Century

Research Consultation 1. Steven E. Hyman, M.D., on National Institute of Mental Health 101

Scientific and Clinical Report Sessions

Session 10. Economic Issues in Patient Care

29. Evaluating Payor-Type Effects on Adolescent Care Thomas W. Lane, Ph.D.

30. Withdrawn

31. Care Coordination Reduces Inpatient Costs Laurence P. Karper, M.D.

Session 11. Novel Issues in the Treatment of Mood Disorders

32. Combined Treatment for Major Depression: Does It Save Hospital Days? Antonio Angreoli, M.D.

33. A Doubled-Blind, Randomized 12-Week Comparison of Nortriptyline and Paroxetine in the Treatment of Late-Life Depression Benoit H. Mulsant, M.D.

34. Fish Consumption and Depressive Symptoms in the Population Antti Tanskanen, M.D.

Session 12. Child and Adolescent Psychopharmacology

35. Novel Antipsychotic in ADHD with Conduct Disorder Mohammad Z. Hussain, M.D.

36. Compliance with Antiseizure Medication in Adolescent Psychiatric Patients David L. Pogge, Ph.D.

37. Trends in Psychotropic Medication Use Among Youth Elizabeth L. McGarvey, Ed.D.

Session 13. Treatments and Outcomes in Anxiety Disorders

38. Function and Well-Being of Primary Care Patients with Anxiety Disorders Risa Weisberg, Ph.D.

39. Use of Alternative Therapies Among Patients with Anxiety Disorders Michael A. Van Ameringen, M.D.

40. Outcome in Anxiety Disorders Oscar R. Carrion, M.D.

Session 14. Impact of the Doctor-Patient Relationship on Medical Treatment

41. Attachment Theory and Adherence to Medical Treatment Paul Ciechanowski, M.D.

42. A Pilot Study of Herbal Remedy Use by Psychiatric Patients Cornelia W. Lange, M.D.

43. What Can Be Learned from the Placebo Effect? Roger Peele, M.D.

Session 15. Managed Care Issues

44. Benefits Managers’ Views on Mental Health Bentson H. McFarland, M.D.

45. The Impact of Managed Care Mark Freeman, M.P.A.

46. Risk Management in Shared Treatment Eugene L. Lowenkopf, M.D.

Session 16. Societal Issues in Mental Illness

47. Major Depression and Mothers’ Marital Transition Terrance J. Wade, Ph.D.

48. Outpatient Commitment in New York: From Pilot Project to State Law Howard W. Telson, M.D.

49. Six-Month Follow-Up of the Nairobi Embassy Bombing Pius A. Kigamwa, M.D.

Session 17. Special Issues in Mood Disorders

50. Quality of Life After Cognitive-Behavior Therapy Gerhard Lenz, M.D.

51. Secular Trend of Violent Methods in Suicide Victims Zoltan Rihmer, M.D.

52. An Open Study of Olanzapine and Fluoxetine for Psychotic Depression: Interim Analyses John D. Matthews, M.D.

Session 18. Alcohol- and Drug-Related Disorders

53. Impulsivity, Serotonin, and Adolescent Alcohol Abuse National Institute on Alcohol Abuse and Alcoholism; Paul H. Scloff, M.D.

54. DWI Prevention: The Psychiatrist’s Role National Institute on Alcohol Abuse and Alcoholism; Bryce Templeton, M.D.

55. Self-Help Strategies Among Substance Abusers Joseph J. Westermeyer, M.D.

Component Workshops

CW23. Paul Ricoeur in Dialogue with American Psychiatrists APA Committee on Religion and Psychiatry Chairperson: Reverend Clark S. Aist, Ph.D.

CW24. Lesbian, Gay, Bisexual, and Transgendered Residents: Challenges in Training APA Northern California Psychiatric Society’s Committee on Lesbian, Gay, Bisexual, and Transgender Issues Chairperson: Dan H. Karasic, M.D.

CW25. Analyze This: Psychiatry, Culture, and the Media APA/Center for Mental Health Services Minority Fellows and APA/AstraZeneca Minority Fellows Co-Chairpersons: Varanise C. Booker, M.D., and Tracy L. Benford, M.D.

CW26. Split Therapy and the Psychiatric Resident APA Committee of Residents and Fellows Chairperson: Geoffrey M. Gabriel, M.D.

CW27. Patient Autonomy and Paternalism Across Cultures APA Council on International Psychiatry Co-Chairpersons: Ramaswamy Viswanathan, M.D., and Jeffrey L. Geller, M.D.

CW28. Risk-Management Issues in Psychiatric Practice APA Psychiatrists’ Purchasing Group Inc. and APA Committee to Monitor APA’s Relationship with the Professional Liability Insurance Program Chairperson: Alan I. Levenson, M.D.

CW29. Facing the Changing Realities of Physician Stress APA Committee on Physician Health, Illness, and Impairment Chairperson: Richard F. Limoges, M.D.

CW30. Latin America: Social and Political Turmoil and PTSD APA Committee of Hispanic Psychiatrists Chairperson: Oscar E. Perez, M.D.

Issue Workshops

IW38. The Real Spice Girls: Black Feminism Through Song Chairperson: Yvonne B. Ferguson, M.D.

IW39. Residency Training: International Perspectives Co-Chairpersons: Michelle Riba, M.D., and Allan Tasman, M.D.

IW40. Problematic Excessive Sexual Behavior Co-Chairpersons: Reid Finlayson, M.D., and John R. Sealy, M.D.

IW41. Management of Difficult Schizophrenia Co-Chairpersons: Michael Y. Hwang, M.D. and Samuel G. Siris, M.D.

IW42. Strategies to Better Implement the World Psychiatric Association Educational Programs The World Psychiatric Association Chairperson: Roger M. Montenegro, M.D.

IW43. Balint Groups: Psychological Learning for Physicians Chairperson: Roy W. Menninger, M.D.

IW44. Shared Care: The Canadian Psychiatric Association and the College of Family Physicians of Canada Initiative Co-Chairpersons: Nick S. Kates, M.B., and Marilyn Craven, M.D.

11 a.m. - 2 p.m.

Media Programs

Session 12. The Trauma and Tragedy of Combat: A Stanley Kubrick Tribute

19. Full Metal Jacket

Session 13. The Doctor-Patient Relationship

20. Films in Teaching Psychiatry, Diversity, Morality, and Healing

Noon-1:30 p.m.

Forums

4. Beyond Just Watching Hate Crimes: In or Into the 21st Century Chairperson: Leah J. Dickstein, M.D.

5. Sex, Drugs (Not Rock & Roll) National and International Politics: Public Versus Private Morality Chairperson: David M. McDowell, M.D.

6. Maternity Leave During Psychiatry Residency Training Chairperson: Samantha E. Meltzer-Brody, M.D.

Noon-2 p.m.

New Research Poster Session 7

1 p.m.-5 p.m.

CME Courses 78-84

2 p.m.-3:30 p.m.

Lectures

L16. Depression in the Medically Ill K. Ranga R. Krishnan, M.D., Distinguished Psychiatrist Lecture Series

L17. To Be Announced Andrew Solomon

2 p.m.-5 p.m.

Media Sessions

Session 15. The Doctor-Patient Relationship

22. The Therapeutic Relationship in Hollywood Cinema

Session 14. The Holocaust: Five Stories, 50 Years Later

21. The Last Days

Symposia

S25. DSM-V  Personality Disorders: Towards an Empirically Based Dimensional Classification

A. A Stepwise Psychobiological Classification C. Robert Cloninger, M.D.

B. A Two-Component Structure for Classifying Personality Disorder John Livesley, M.D.

C. Five-Factor Model of Personality Disorders Thomas A. Widiger, Ph.D.

D. Empirical Prototypes Based on Clinical Observation Drew Westen, Ph.D.

S26. The Doctor-Patient Relationship in the Americas Inter-American Council of Psychiatric Organizations

A. Practice of Psychopharmacology and the Doctor-Patient Relationship Antonio Pacheco, M.D.

B. Influence of Culture in Patient-Psychiatrist Relationship Carlos Leon-Andrade, M.D.

C. Cultural Issues in the Doctor-Patient Relationship Miguel R. Jorge, M.D.

D. Physical or Mental Chronic Illness: Characteristics of the Doctor-Patient Relationship Rodolfo D. Fahrer, M.D.

E. Language and Doctor-Patient Relations in Psychiatry Roberto E. Chaskel, M.D.

S27. Quality Indicators in Psychiatry APA Council on Quality Improvement

A. Clinically Based Quality Indicators John M. Oldham, M.D.

B. Quality Indicators and Practice Guidelines John S. McIntyre, M.D.

C. Conformance with Quality Indicators in Routine Practice Joyce C. West, M.P.P.

D. Quality Measurement in a Clinical Facility Lloyd I. Sederer, M.D.

S28. The Psychiatric Hospital in the 21st Century

A. What Works Best for Whom and at the Lowest Cost? Efram Bleiberg , M.D.

B. Partners, Psychiatry, and the Mental Health System Gary L. Gottlieb, M.D.

C. Academic Challenges in the Psychiatric Hospital in the 21st Century Sheldon I. Miller, M.D.

D. The Montefiore and University Behavioral Associates’ Experience Bruce J. Schwartz, M.D.

E. The Reinvention of Sheppard Pratt Steven S. Sharfstein, M.D.

S29. The Coming of Age of the Bipolar Spectrum

A. Bipolarity at 2000: Progress Beyond Classic Mania Hagop S. Akiskal, M.D.

B. Agitated Depression as a Mixed State Athanasio Koukopoulos, M.D.

C. Are Impulse Control Disorders Bipolar? Susan L. McElroy, M.D.

D. Anticonvulsant Augmentation in Borderline Personality-II and Borderline Personality-III Olavo D. Pinto, M.D.

E. Advances in Treatments for Bipolar Disorder Charles L. Bowden, M.D.

S30. Evolution of Care: Schizophrenia and Substance Abuse

A. Integrating Service for Substance Abuse and Schizophrenia David J. Hellerstein, M.D.

B. Effects of Assertive Outreach in the Dually Diagnosed Patient Christian R. Miner, Ph.D.

C. Dual Recovery Therapy and Motivation Douglas M. Ziedonis, M.D.

D. Alliance and Engagement in Substance-Abusing Schizophrenia Patients Richard N. Rosenthal, M.D.

E. Skills Training for Substance-Abusing Patients Andrew L. Shaner, M.D.

S31. Psychosocial Rehabilitation Advances for the Severely and Persistently Mentally Ill

A. Impact of Public Sector Managed Care on Psychosocial Rehabilitation Clifton R. Tennison Jr., M.D.

B. Integrating Psychiatric Rehabilitation and Psychiatric Care Selby C. Jacobs, M.D.

C. Psychosocial Rehabilitation: Emerging Best Practices in Recovery Dale P. Svendsen, M.D.

D. Report from the American Psychiatric Association’s Psychosocial Rehabilitation Committee Troy L. Thompson II, M.D.

S32. Eating Disorders 2000: Causes, Patterns, and Outcomes

A. Susceptibility Factors in Eating Disorders Walter H. Kaye, M.D.

B. Predictions of Simple and Complex PTSD in Bulimia Nervosa Marcia E. Rorty, Ph.D.

C. Inpatients with Eating Disorders: Changing Epidemiology Katherine A. Halmi, M.D.

D. The Impact of Eating Disorders on Babies and Bones David B. Herzog, M.D.

E. Outcome of Gastric Bypass for Bedridden and Nonbedridden Obese Patients James E. Mitchell, M.D.

S33. Domestic Violence and Health Interventions U.S. Department of Justice’s Office for Victims of Crime and APA Task Force on Violence and APA Committee on Family Violence and Sex Abuse

A. Domestic Violence: An Overview Sandra J. Kaplan, M.D.

B. Domestic Violence: Legal Trends Diane Geraghty, J.D.

C. Meeting the Mental Health Needs of Battered Women: Critical Review of Treatment Interventions Carole L. Warshaw, M.D.

D. Mental Health Treatment of the Domestic Violence Batterer Donald G. Dutton, Ph.D.

E. Collaborative Approaches to Children Exposed to Violence: The Experience of a Police/Mental Health Partnership Miriam Berkman, M.S.W.

S34. New Trends in Emergency Psychiatry in North America and Europe

A. Emergency Psychiatry in the U.S.: Facing the Managed Care Revolution James R. Hillard, M.D.

B. The Challenges of Emergency Psychiatry in Europe Michel De Clercq, M.D.

C. Canadian Versus American Psychiatric Emergency Services Suzanne Lamarre, M.D.

D. Innovating Acute Treatment: A Swiss Pilot Project Antonio Andreoli, M.D.

S35. Antipsychotic Medications and Sexuality

A. Review of Pathomechanisms of Sexual Dysfunction Secondary to Antipsychotic and Antidepressant Medications R. Taylor Segraves, M.D.

B. Sexuality and the Cost of Compliance for Consumers Francine Chisholm, B.A.

C. Sexual Problems in a Women’s Clinic for Schizophrenia Mary V. Seeman, M.D.

D. Development of a Scale to Assess Sexual Functioning Ruth A. Dickson, M.D.

E. Sexual Dysfunctions in Patients on Antipsychotics Rikus Knegtering

S36. Recovered Memory: Law, Science, and the Clinician

A. Memory Distortion: Data, Theory, and Application Daniel L. Schacter, Ph.D.

B. Recovered Memories: A Multidisciplinary Analysis Christopher Barden, Ph.D.

C. Justice and Pseudoscience in the Memory Wars Alan W. Scheflin, LL.M.

D. Standard Practices with Recovered Memories Paul R. McHugh, M.D.

E. Recovery and Memory David Spiegel, M.D.

S37. The Psychotherapy of Prescribing

A. Overview: Prescriptions of Medications and Doctor-Patient Relationships Michael D. Jibson, M.D.

B. Factors Affecting Adherence to a Pharmacotherapeutic Treatment James M. Ellison, M.D.

C. Understanding the Symbolic Value of Medications Jonathan M. Metzl, M.D.

S38. The Many Faces of Transference in Everyday Clinical Care: Part 2 American Academy of Psychoanalysis and the American Psychoanalytic Association

A. The Therapeutic Relationship: Cultural Influences on Boundaries Silvia W. Olarte, M.D.

B. Impact of the Changing Social Context on the Doctor-Patient Relationship Edward R. Shapiro, M.D.

C. The Active Engagement of Patients in Supportive Relationships Milton Viederman, M.D.

D. How Psychodynamic Therapists Modify Behavior Saul Tuttman, M.D.

S39. Neuroscience of Alcoholism: Treatment Implications National Institute on Alcohol Abuse and Alcoholism

A. Extracellular and Intracellular Signals in Alcohol Dependence Boris Tabakoff, Ph.D.

B. Are There Genes for Alcoholism? Neurobiology of Alcohol Reward and Dependence George F. Koob, Ph.D.

C. Neurobiology of Alcohol Dependence and Withdrawal Howard C. Becker, Ph.D.

D. Neurobehavioral Aspects of Alcohol Craving and Relapse Raymond F. Anton, M.D.

S40. Rehabilitation as a Dynamic Process

A. The World Psychiatric Association’s Consensus Statement on Psychosocial Rehabilitation Robert Cancro, M.D.

B. Program Retention Prevents Relapse Better Than Program Type Martin Gittelman, Ph.D.

C. Progress in Deinstitutionalization in Japan Naotaka Shinfuku, M.D.

D. Sector Treatment in Germany Michael Stark, M.D.

E. Pressures on Sectorization in France Jacques M. Dubuis, M.D.

S41. Mergers and Integration of VA Mental Health Services

A. Consolidation of Psychiatric Services at the VA Chicago Health Care System Surinder S. Nand, M.D.

B. VA Maryland Health Care System: An Integrated Continuum of Mental Health Care Christine LaGana, Ph.D.

C. VISN Mental Health Service Line Richard A. McCormick, Ph.D.

S42. Minority Veterans: Obstacles to Mental Health Care

A. A Coding Scheme for Barriers to Psychiatric Care Judith M. Garrard, Ph.D.

B. Veterans Administration Minority Staff Identifies Obstacles to Mental Health Services Jose M. Canive, M.D.

C. Veterans Administration Mental Health Workers and Barriers to Care Joseph J. Westermeyer, M.D.

D. Psychiatric Care Barriers: 2000 Veteran Reports Ross D. Crosby, Ph.D.

S43. The Treatment of Psychiatrically Ill HIV-Infected Patients

A. Mood Disorders Stephen J. Ferrando, M.D.

B. Psychotic Disorders Francine Cournos, M.D.

C. Anxiety Disorders J. Stephen McDaniel, M.D.

D. Pain Disorders William Breitbart, M.D.

S44. Political Violence in the New Millennium

A. Millennial Hopes and the Psychology of Mass Violence David A. Rothstein, M.D.

B. When History Is a Nightmare Stevan M. Weine, M.D.

C. Justice and Righteousness After Genocide Kenneth B. Dekleva, M.D.

D. Virtual Group Dynamics and the Propagation of Hatred Jerrold M. Post, M.D.

S45. The First Interview

A. Computerized Psychological Testing: Expanding Psychiatrists’ Clinical and Fiscal Potentials Maurice Rappaport, M.D.

B. Evaluation of the Ill Physician Michael Myers, M.D.

C. Computerized Psychiatric Diagnostic Interview for DSM-IV Mark Zetin, M.D.

S46. Mood and Menopause: Treating Women in Midlife

A. Psychotherapy During the Perimenopause Nada L. Stotland, M.D.

B. Gender-Based Biology and Public Policy Florence Haseltine, M.D.

C. Mood and Menopause: Clinical Issues in Treating Midlife Women Diana L. Dell, M.D.

D. Psychotropic Medications in the Perimenopause and Menopause Margaret F. Jensvold, M.D.

E. Promoting Informed Decision-Making About Hormone-Replacement Therapy Lori A. Bastian, M.D.

S47. Electronic Records: The End of Confidentiality?

A. Computerized Psychiatric Records Today: Can They Be Protected? David P. Olson, M.D.

B. Electronic Patient Records: The Ethical Challenges Ronald J. Draper, M.D.

C. Will the HIPAA Challenge Have Been Overcome by the American Psychiatric Association in 2000? Francoise Gilbert, J.D.

D. Encryption: What It Is and How to Use It Robert C. Hsiung, M.D.

E. Responsible Management of Consumer Information Mary Graham

S48. Substance Abuse: Cutting-Edge Treatments

A. Advances in Smoking Cessation Alexander H. Glassman, M.D.

B. Treatment of Heroin Dependence Herbert D. Kleber, M.D.

C. Treatment of Cocaine Dependence Marian W. Fischman, Ph.D.

D. Treatment of Alcohol and Marijuana Dependence David M. McDowell, M.D.

E. Treatment of Comorbid Conditions Frances R. Levin, M.D.

S49. Clinical Challenges to the Psychiatrist of Faith

A. Clinical Exploration of the Patient’s World View Irving S. Wiesner, M.D.

B. Challenges to the Psychiatrist of Hindu Faith Nalini V. Juthani, M.D.

C. Value Conflicts for Observant Jewish Psychiatrists Abba E. Borowich, M.D.

D. A Catholic Synthesis of Faith and Reason Judith Moss Hughes, M.D.

E. Christian Faith and Practice: A Delicate Balance Mark E. Servis, M.D.

S50. How to Launch a Successful Private Practice APA Committee of Early Career Psychiatrists

A. Balancing Multiple Roles in Private Practice William E. Callahan Jr., M.D.

B. Personal Factors Leading to a Successful Private Practice Ann S. Maloney, M.D.

C. Streamlining Overhead in Private Practice Barry W. Wall, M.D.

D. Marketing Your Unique Private Practice Keith W. Young, M.D.

Telecommunication Session

Session 2. Varieties of Electronic Medical Records

4. Continuous Monitoring of Symptoms and Medications

5. The University of Michigan’s Electronic Medical Record Model

6. Psychiatrist-Programmed Electronic Medical Records

7. CAPER Software

2 p.m. - 5:30 p.m.

Review of Psychiatry, Part III: Ethnicity and Psychopharmacology Chairperson: Pedro Ruiz, M.D.

10. Psychopharmacotherapy in the Context of Culture and Ethnicity Keh-Ming Lin, M.D.

11. Issues in the Pharmacotherapy of African Americans William B. Lawson, M.D.

12. A Closer Look at the Hispanic Response to Psychotropic Medications Ricardo P. Mendoza, M.D.

13. Ethnopsychopharmacology of Asians Edmond H. Pi, M.D.

14. Ethnopsychopharmacology in the Public Sector Roy V. Varner, M.D.

3 p.m.-5 p.m.

New Research Poster Session 8

4 p.m.-5 p.m.

Media Program

Session 16. The Doctor-Patient Relationship

23. Training Issues in Short-Term Dynamic Psychotherapy

7 p.m.-10 p.m.

Industry-Supported Symposia

IS34. Manic Depressive Illness: An Update Supported by Solvay Pharmaceuticals Inc.

A. Bipolar Disorder and Genetics: A Clinician’s Perspective J. Raymond DePaulo Jr., M.D.

B. Molecular Mechanisms Underlying Mood Stabilization on MDI Husseini K. Manji, M.D.

C. Brain Anatomy and Function in Bipolar Disorder Harold A. Sackeim, Ph.D.

D. Suicide in Bipolar Disorders Jan A. Fawcett, M.D.

E. Pharmacological Treatment: Challenges and Controversies Frederick K. Goodwin, M.D.

F. Manic-Depressive Illness: An Update on Psychological Issues Kay R. Jamison, Ph.D.

IS35. Neurotransmitters and Depression: New Possibilities Supported by Glaxo Wellcome Inc.

A. Neurotransmitters in Depression Jack D. Barchas, M.D.

B. Molecular Adaptations to Drugs Used for Depression Chris J. Evans, Ph.D.

C. Depletion of Neurotransmitters in Humans Pedro L. Delgado, M.D.

D. The Targeted Treatment of Depression Richard J. Metzner, M.D.

IS36. Psychiatry in Uncharted Territory: Assessing and Treating Psychiatric Conditions in Medical Patients Supported by Forest Laboratories Inc.

A. Broken Hearts: Ischemic Heart Disease, Depression, and Gender Donna E. Stewart, M.D.

B. Effective Treatment of Minor Depression in Primary Care Ellen Frank, Ph.D.

C. Effectiveness of Paroxetine and Problem-Solving Therapy for Primary Care Patients with Dysthymia Wayne J. Katon, M.D.

D. Improving Care for Panic in Primary Care Peter P. Roy-Byrne, M.D.

E. Primary Care Training Improves Depression Outcomes Kathryn M. Rost, Ph.D.

IS37. Defining Bipolar Disorder: A Public Health Challenge Supported by Abbott Laboratories

A. A New Screening Tool for Bipolar Disorder: The Mood Disorder Questionnaire Robert M.A. Hirschfeld, M.D.

B. Cost-Effective Pathways for Bipolar Disorder Gary S. Sachs, M.D.

C. Rapid Stabilization of Mood and Psychiatric Symptoms in Mania Paul E. KeckJr., M.D.

D. Pharmacologic Treatment for Women with Bipolar Disorder Lauren B. Marangell, M.D.

E. Recognition and Management of Bipolar Disorder in Children and Adolescents Neal D. Ryan, M.D.

IS38. Adult ADHD: Research Findings and Clinical Practice Supported by Shire Richwood

A. Age-Dependent Decline of ADHD Symptoms Joseph Biederman, M.D.

B. Neuroimaging in Patients with ADHD Jean A. Frazier, M.D.

C. Genetics of Adult ADHD Stephen V. Faraone, Ph.D.

D. Cholinergic Mechanisms and ADHD: Treatment Implications Timothy E. Wilens, M.D.

E. Efficacy and Tolerability of a Mixed Amphetamine Salts Compound in Adults with ADHD Thomas J. Spencer, M.D.

IS39. Cognition in Schizophrenia: Maximizing Recovery Supported by U.S. Pharmaceuticals, Pfizer Inc.

A. Cognitive Impairment and Outcome in Schizophrenia Herbert Y. Meltzer, M.D.

B. Cognition: The Link to Functional Outcomes Michael F. Green, Ph.D.

C. Cognition-Enhancing Treatments in Schizophrenia John W. Newcomer, M.D.

D. Cognitive Rehabilitation for Schizophrenia Alan S. Bellak, Ph.D.

Media Sessions

Session 17. The Holocaust: Life Is Beautiful

24. Life Is Beautiful: The Holocaust as Fable

Session 18. The Doctor-Patient Relationship: A Rare Realistic Portrayal

25. Good Will Hunting

Symposia

S51. Applying Virtual Environments in Psychiatry

A. An Introduction to Virtual Environments Milton Huang, M.D.

B. Virtual Environment for Neuropsychiatric Assessment and Rehabilitation Albert A. Rizzo, Ph.D.

C. Virtual Humans: The Future Occupants of Virtual Reality Norman E. Alessi, M.D.

D. A Virtual Future for Psychiatry Mark Wiederhold

S52. Arab Perspective on Psychotic Disorders Arab American Psychiatric Association

A. Arab Perspective on Psychosis Nasser F. Loza, M.B.

B. Transcultural Aspects of Expressed Emotions in Relapse of Psychotics Ahmed M.F. Okasha, M.D.

C. Prevalence of Early Postpartum Psychiatric Morbidity in Dubai: A Treatment Perspective Mohammed Abou-Saleh, M.D.

D. Structured Clinical Interview in Psychotic Disorders: Arab Perspective Adel Sadek, M.D.

S53. One Psychiatry, Two Cultures, and Scores of Treatment Guidelines: Vive La Difference

A. Development of Treatment Guidelines in the U.S. John S. McIntyre, M.D.

B. Interview and Clinical Assessment in France Jean-Jacques Laboutiere, M.D.

C. Practice Guidelines for the Psychiatric Evaluation of Adults Ronald A. Shellow, M.D.

D. Consensus Conference and Guidelines in Paris Vivione Kovess

E. The 1999 Expert Consensus Guidelines for the Treatment of Schizophrenia Allen J. Frances, M.D.

F. Treatment of Schizophrenia: The French Consensus Statement Francois C. Petitjean, M.D.

S54. Psychopharmacological Approaches to the Athletic and Exercise Population International Society for Sport Psychiatry

A. Pharmacologic Management of Anxiety and Mood Disorders in the Athlete Antonia L. Baum, M.D.

B. Diagnosis and Psychiatric Treatment of Athletes Ira D. Glick, M.D.

C. Eating Disorders and ADHD in Athletes: Psychopharmacologic Management Issues Robert W. Burton, M.D.